Literature DB >> 35171326

Coamplification of 12q15 and 12p13 and homozygous CDKN2A/2B deletion: synergistic role of fibrosarcomatous transformation in dermatofibrosarcoma protuberans with a cryptic COL1A1-PDGFB fusion.

Yang Lu1, Tao Li2, Min Chen1, Heng Peng1, Tianhai Du1, Yan Qiu1, Hongying Zhang3.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is characterized by collagen type I alpha 1 chain-platelet-derived growth factor B chain (COL1A1-PDGFB) fusion. We present a case of fibrosarcomatous DFSP with lung metastasis in a 53-year-old man. Histologically, the primary and metastatic tumors were composed of high-grade fibrosarcomatous component with varying myxoid changes, while only a small focus of the classic DFSP element was identified in the primary lesion. No evidence of COL1A1-PDGFB fusion was identified by routine fluorescence in situ hybridization (FISH). Subsequent next-generation sequencing and COL1A1 break-apart FISH identified the fusion. In addition, coamplification of 12q15 and 12p13, along with CDKN2A/2B deletion, was confirmed to be limited to the fibrosarcomatous component. The current case is a novel FS-DFSP with cryptic COL1A1-PDGFB fusion. This is the first published example of DFSP harboring coamplification of 12q and 12p sequences. More importantly, the genetic aberrations restricted to the fibrosarcomatous component indicated a synergistic role of higher-grade progression.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  12p amplification; COL1A1-PDGFB fusion; Dermatofibrosarcoma protuberans; Fibrosarcomatous transformation; MDM2 amplification

Mesh:

Substances:

Year:  2022        PMID: 35171326     DOI: 10.1007/s00428-022-03297-5

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  19 in total

1.  The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.

Authors:  Jared J Abbott; Andre M Oliveira; Antonio G Nascimento
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

2.  Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.

Authors:  Yuka Hiraki-Hotokebuchi; Yuichi Yamada; Kenichi Kohashi; Hidetaka Yamamoto; Makoto Endo; Nokitaka Setsu; Kuma Yuki; Takamichi Ito; Yukihide Iwamoto; Masutaka Furue; Yoshinao Oda
Journal:  Hum Pathol       Date:  2017-07-13       Impact factor: 3.466

3.  Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.

Authors:  Bérengère Dadone-Montaudié; Laurent Alberti; Adeline Duc; Lucile Delespaul; Tom Lesluyes; Gaëlle Pérot; Agnès Lançon; Sandrine Paindavoine; Ilaria Di Mauro; Jean-Yves Blay; Arnaud de la Fouchardière; Frédéric Chibon; Marie Karanian; Gaëtan MacGrogan; Valérie Kubiniek; Frédérique Keslair; Nathalie Cardot-Leccia; Audrey Michot; Virginie Perrin; Yanis Zekri; Jean-Michel Coindre; Franck Tirode; Florence Pedeutour; Dominique Ranchère-Vince; François Le Loarer; Daniel Pissaloux
Journal:  Mod Pathol       Date:  2018-06-28       Impact factor: 7.842

4.  Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors.

Authors:  Hongying Zhang; Michele Erickson-Johnson; Xiaoke Wang; Jennifer L Oliveira; Antonio G Nascimento; Frank H Sim; Doris E Wenger; Renata Q Zamolyi; Vera L Pannain; Andre M Oliveira
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

5.  CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.

Authors:  Grant Eilers; Jeffrey T Czaplinski; Mark Mayeda; Nacef Bahri; Derrick Tao; Meijun Zhu; Jason L Hornick; Neal I Lindeman; Ewa Sicinska; Andrew J Wagner; Jonathan A Fletcher; Adrian Mariño-Enriquez
Journal:  Mol Cancer Ther       Date:  2015-04-07       Impact factor: 6.261

6.  Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.

Authors:  Jared J Abbott; Michele Erickson-Johnson; Xiaoke Wang; Antonio G Nascimento; Andre M Oliveira
Journal:  Mod Pathol       Date:  2006-09-15       Impact factor: 7.842

7.  Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.

Authors:  Michael G Swaby; Harry L Evans; Christopher D M Fletcher; Victor G Prieto; Kayuri U Patel; Dina C Lev; Dolores Lòpez-Terrada; Alexander J F Lazar; Wei-Lien Wang
Journal:  Am J Dermatopathol       Date:  2011-06       Impact factor: 1.533

8.  Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.

Authors:  M Hisaoka; S Okamoto; Y Morimitsu; S Tsuji; H Hashimoto
Journal:  Virchows Arch       Date:  1998-10       Impact factor: 4.064

9.  Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans.

Authors:  Tomonari Takahira; Yoshinao Oda; Sadafumi Tamiya; Hidetaka Yamamoto; Kenichi Kawaguchi; Chikashi Kobayashi; Shinya Oda; Yukihide Iwamoto; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

10.  Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.

Authors:  Silvia Stacchiotti; Annalisa Astolfi; Alessandro Gronchi; Andrea Fontana; Maria A Pantaleo; Tiziana Negri; Monica Brenca; Marcella Tazzari; Milena Urbini; Valentina Indio; Chiara Colombo; Stefano Radaelli; Silvia Brich; Angelo P Dei Tos; Paolo G Casali; Chiara Castelli; Gian Paolo Dagrada; Silvana Pilotti; Roberta Maestro
Journal:  Mol Cancer Res       Date:  2016-06-02       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.